Holen Sie sich die Stockscreener-App
7.26
1.22%
-0.09
Handel nachbörslich:
7.25
-0.010
-0.14%
Schlusskurs vom Vortag:
$7.35
Offen:
$7.5
24-Stunden-Volumen:
1.35M
Relative Volume:
1.06
Marktkapitalisierung:
$295.02M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-8.8537
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
-2.55%
1M Leistung:
-46.66%
6M Leistung:
-77.25%
1J Leistung:
-84.69%
1-Tages-Spanne:
$7.24
$7.61
1-Wochen-Bereich:
$7.205
$7.82
52-Wochen-Spanne:
$6.32
$58.23
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.26 | 302.75M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Shareholder Alert: Robbins LLP Informs Investors of the RxSight,Inc. Securities Fraud Class Action Lawsuit - ACCESS Newswire
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead the RxSight Class Action Lawsuit - GlobeNewswire Inc.
Is RxSight Inc. a good long term investmentMarket-beating returns - jammulinksnews.com
What drives RxSight Inc. stock priceAccelerated wealth building - jammulinksnews.com
RXST LOSS ALERT: Lose Money on RxSight, Inc. (NASDAQ: - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - PR Newswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights – RXST - The Globe and Mail
RxSight Shares Fall 38% on Q2 ‘Underperformance’ - Orange County Business Journal
RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm - ETX View
RXST SECURITIES NEWS: Did RxSight, Inc. (NASDAQ:RXST) - GlobeNewswire
What analysts say about RxSight Inc. stockRapid return acceleration - Jammu Links News
RxSight Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Time To Worry? Analysts Just Downgraded Their RxSight, Inc. (NASDAQ:RXST) Outlook - simplywall.st
What Does The Future Hold For RxSight, Inc. (NASDAQ:RXST)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance
Revenue Downgrade: Here's What Analysts Forecast For RxSight, Inc. (NASDAQ:RXST) - 富途牛牛
Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal
RXST INVESTIGATION: RxSight, Inc. (NASDAQ:RXST) 38% Stock - GlobeNewswire
(RXST) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
RxSight (NASDAQ:RXST) Cut to Equal Weight at Morgan Stanley - Defense World
RxSight's (RXST) Deteriorating Fundamentals and Regulatory Risks: A Cautionary Tale for Investors - AInvest
RXST BREAKING NEWS: BFA Law is Investigating RxSight, Inc. for Securities Fraud; Contact the Firm about how to Potentially Recover Investment Losses - The Globe and Mail
RxSight Downgraded After Q2 Revenue Miss, FY23 Guidance Cut. - AInvest
How RxSight Inc. stock performs during market volatilityChart Breakout Alert - Newser
RxSight's Plunge: Securities Fraud Allegations and the Uncertain Future for RXST Shareholders - AInvest
Investigation Continues: RxSight Investors Urged to Contact Glancy Prongay & Murray LLP - AInvest
Securities Fraud Investigation Into RxSight, Inc. (RXST) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - The Globe and Mail
RxSight, Inc. (RXST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - The Globe and Mail
RXSIGHT ALERT: Bragar Eagel & Squire, P.C.Announces - GlobeNewswire
Robbins LLP is Investigating the Officers and Directors of - GlobeNewswire
Robbins LLP is Investigating the Officers and Directors of RxSight, Inc. (RXST) to Determine if They Breached Fiduciary Duties Owed to Shareholders - TradingView
Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE) - Seeking Alpha
Why RxSight Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser
RxSight stock rating downgraded by Morgan Stanley on growth concerns - Investing.com Canada
Morgan Stanley Downgrades RxSight Inc. (RXST) to Equalweight - StreetInsider
What makes RxSight Inc. stock price move sharplyFree Stock Index Interpretation - Newser
Top 3 Health Care Stocks That Could Blast Off In July - Benzinga
RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN
The Biotech Bubble: RxSight's Downfall and the Dangers of Overvalued Innovation - AInvest
RxSight (NASDAQ:RXST) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
INVESTOR ALERT: Investigation of RxSight, Inc. (RXST) Announced by Holzer & Holzer, LLC - GlobeNewswire
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):